Cargando…

cDNA Cloning, Overexpression, Purification and Pharmacologic Evaluation for Anticancer Activity of Ribosomal Protein L23A Gene (RPL23A) from the Giant Panda

RPL23A gene encodes a ribosomal protein that is a component of the 60S subunit. The protein belongs to the L23P family of ribosomal proteins, which is located in the cytoplasm. The purpose of this paper was to explore the structure and anti-cancer function of ribosomal protein L23A (RPL23A) gene of...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Bing, Hou, Yi-Ling, Hou, Wan-Ru, Zhang, Si-Nan, Ding, Xiang, Su, Xiu-Lan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International (MDPI) 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3292012/
https://www.ncbi.nlm.nih.gov/pubmed/22408443
http://dx.doi.org/10.3390/ijms13022133
_version_ 1782225217080262656
author Sun, Bing
Hou, Yi-Ling
Hou, Wan-Ru
Zhang, Si-Nan
Ding, Xiang
Su, Xiu-Lan
author_facet Sun, Bing
Hou, Yi-Ling
Hou, Wan-Ru
Zhang, Si-Nan
Ding, Xiang
Su, Xiu-Lan
author_sort Sun, Bing
collection PubMed
description RPL23A gene encodes a ribosomal protein that is a component of the 60S subunit. The protein belongs to the L23P family of ribosomal proteins, which is located in the cytoplasm. The purpose of this paper was to explore the structure and anti-cancer function of ribosomal protein L23A (RPL23A) gene of the Giant Panda (Ailuropoda melanoleuca). The cDNA of RPL23A was cloned successfully from the Giant Panda using RT-PCR technology. We constructed a recombinant expression vector containing RPL23A cDNA and over-expressed it in Escherichia coli using pET28a plasmids. The expression product obtained was purified by using Ni chelating affinity chromatography. Recombinant protein of RPL23A obtained from the experiment acted on Hep-2 cells and human HepG-2 cells, then the growth inhibitory effect of these cells was observed by MTT (3-[4,5-dimethyl-2-thiazolyl]-2,5-diphenyl-2H-tetrazolium bromide) assay. The result indicated that the length of the fragment cloned is 506 bp, and it contains an open-reading frame (ORF) of 471 bp encoding 156 amino acids. Primary structure analysis revealed that the molecular weight of the putative RPL23A protein is 17.719 kDa with a theoretical pI 11.16. The molecular weight of the recombinant protein RPL23A is 21.265 kDa with a theoretical pI 10.57. The RPL23A gene can be really expressed in E. coli and the RPL23A protein, fusioned with the N-terminally His-tagged protein, gave rise to the accumulation of an expected 22 KDa polypeptide. The data showed that the recombinant protein RPL23A had a time- and dose-dependency on the cell growth inhibition rate. The data also indicated that the effect at low concentrations was better than at high concentrations on Hep-2 cells, and that the concentration of 0.185 μg/mL had the best rate of growth inhibition of 36.31%. All results of the experiment revealed that the recombinant protein RPL23A exhibited anti-cancer function on the Hep-2 cells. The study provides a scientific basis and aids orientation for the research and development of cancer protein drugs as well as possible anti-cancer mechanisms. Further research is on going to determine the bioactive principle(s) of recombinant protein RPL23A responsible for its anticancer activity.
format Online
Article
Text
id pubmed-3292012
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Molecular Diversity Preservation International (MDPI)
record_format MEDLINE/PubMed
spelling pubmed-32920122012-03-09 cDNA Cloning, Overexpression, Purification and Pharmacologic Evaluation for Anticancer Activity of Ribosomal Protein L23A Gene (RPL23A) from the Giant Panda Sun, Bing Hou, Yi-Ling Hou, Wan-Ru Zhang, Si-Nan Ding, Xiang Su, Xiu-Lan Int J Mol Sci Article RPL23A gene encodes a ribosomal protein that is a component of the 60S subunit. The protein belongs to the L23P family of ribosomal proteins, which is located in the cytoplasm. The purpose of this paper was to explore the structure and anti-cancer function of ribosomal protein L23A (RPL23A) gene of the Giant Panda (Ailuropoda melanoleuca). The cDNA of RPL23A was cloned successfully from the Giant Panda using RT-PCR technology. We constructed a recombinant expression vector containing RPL23A cDNA and over-expressed it in Escherichia coli using pET28a plasmids. The expression product obtained was purified by using Ni chelating affinity chromatography. Recombinant protein of RPL23A obtained from the experiment acted on Hep-2 cells and human HepG-2 cells, then the growth inhibitory effect of these cells was observed by MTT (3-[4,5-dimethyl-2-thiazolyl]-2,5-diphenyl-2H-tetrazolium bromide) assay. The result indicated that the length of the fragment cloned is 506 bp, and it contains an open-reading frame (ORF) of 471 bp encoding 156 amino acids. Primary structure analysis revealed that the molecular weight of the putative RPL23A protein is 17.719 kDa with a theoretical pI 11.16. The molecular weight of the recombinant protein RPL23A is 21.265 kDa with a theoretical pI 10.57. The RPL23A gene can be really expressed in E. coli and the RPL23A protein, fusioned with the N-terminally His-tagged protein, gave rise to the accumulation of an expected 22 KDa polypeptide. The data showed that the recombinant protein RPL23A had a time- and dose-dependency on the cell growth inhibition rate. The data also indicated that the effect at low concentrations was better than at high concentrations on Hep-2 cells, and that the concentration of 0.185 μg/mL had the best rate of growth inhibition of 36.31%. All results of the experiment revealed that the recombinant protein RPL23A exhibited anti-cancer function on the Hep-2 cells. The study provides a scientific basis and aids orientation for the research and development of cancer protein drugs as well as possible anti-cancer mechanisms. Further research is on going to determine the bioactive principle(s) of recombinant protein RPL23A responsible for its anticancer activity. Molecular Diversity Preservation International (MDPI) 2012-02-16 /pmc/articles/PMC3292012/ /pubmed/22408443 http://dx.doi.org/10.3390/ijms13022133 Text en © 2012 by the authors; licensee Molecular Diversity Preservation International, Basel, Switzerland. http://creativecommons.org/licenses/by/3.0 This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Article
Sun, Bing
Hou, Yi-Ling
Hou, Wan-Ru
Zhang, Si-Nan
Ding, Xiang
Su, Xiu-Lan
cDNA Cloning, Overexpression, Purification and Pharmacologic Evaluation for Anticancer Activity of Ribosomal Protein L23A Gene (RPL23A) from the Giant Panda
title cDNA Cloning, Overexpression, Purification and Pharmacologic Evaluation for Anticancer Activity of Ribosomal Protein L23A Gene (RPL23A) from the Giant Panda
title_full cDNA Cloning, Overexpression, Purification and Pharmacologic Evaluation for Anticancer Activity of Ribosomal Protein L23A Gene (RPL23A) from the Giant Panda
title_fullStr cDNA Cloning, Overexpression, Purification and Pharmacologic Evaluation for Anticancer Activity of Ribosomal Protein L23A Gene (RPL23A) from the Giant Panda
title_full_unstemmed cDNA Cloning, Overexpression, Purification and Pharmacologic Evaluation for Anticancer Activity of Ribosomal Protein L23A Gene (RPL23A) from the Giant Panda
title_short cDNA Cloning, Overexpression, Purification and Pharmacologic Evaluation for Anticancer Activity of Ribosomal Protein L23A Gene (RPL23A) from the Giant Panda
title_sort cdna cloning, overexpression, purification and pharmacologic evaluation for anticancer activity of ribosomal protein l23a gene (rpl23a) from the giant panda
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3292012/
https://www.ncbi.nlm.nih.gov/pubmed/22408443
http://dx.doi.org/10.3390/ijms13022133
work_keys_str_mv AT sunbing cdnacloningoverexpressionpurificationandpharmacologicevaluationforanticanceractivityofribosomalproteinl23agenerpl23afromthegiantpanda
AT houyiling cdnacloningoverexpressionpurificationandpharmacologicevaluationforanticanceractivityofribosomalproteinl23agenerpl23afromthegiantpanda
AT houwanru cdnacloningoverexpressionpurificationandpharmacologicevaluationforanticanceractivityofribosomalproteinl23agenerpl23afromthegiantpanda
AT zhangsinan cdnacloningoverexpressionpurificationandpharmacologicevaluationforanticanceractivityofribosomalproteinl23agenerpl23afromthegiantpanda
AT dingxiang cdnacloningoverexpressionpurificationandpharmacologicevaluationforanticanceractivityofribosomalproteinl23agenerpl23afromthegiantpanda
AT suxiulan cdnacloningoverexpressionpurificationandpharmacologicevaluationforanticanceractivityofribosomalproteinl23agenerpl23afromthegiantpanda